PUBBLICATO IL NUOVO NUMERO DELLA WHO PHARMACEUTICAL NEWSLETTER

Fonte: WHO. N 6, dicembre 2018

E' disponibile il nuovo numero della WHO Pharmaceutical newsletter.

In questo numero:

REGULATORY MATTERS
• Fingolimod
• Fluoroquinolone and quinolone antibiotics
• HMG-CoA reductase inhibitors and fibrates: co-administration
• Hydrochlorothiazide
• Insulin-containing products: cartridges and pre-filled pens
• Ketoconazole
• Lamotrigine
• Lenvatinib
• Ponatinib
• Ritonavir
• Secukinumab
• Zoster and Influenza vaccines

SAFETY OF MEDICINE
• Daclizumab beta
• Dolutegravir
• Fentanyl (transdermal patches)
• Fluoroquinolones
• Nusinersen
• Rivaroxaban
• Ruxolitinib
• Sildenafil

SIGNAL
• Aflibercept and deep vein thrombosis/pulmonary embolism
• Brivudine and 5-fluorouracil – Persistence of a fatal drug-drug interaction
• Ceftriaxone and Hepatitis in Patients 75 Years and Older

FEATURE
• 41st Annual Meeting of Representatives of National Pharmacovigilance Centres participating in the WHO Programme for International Drug Monitoring, Geneva 6-8 November 2018
• Advanced Workshop for Strengthening Pharmacovigilance (PV) Systems and PV Preparedness Geneva, Switzerland, 3-7 December